Breaking News Instant updates and real-time market news.

BLUE

bluebird bio

$131.65

0.15 (0.11%)

05:07
10/11/17
10/11
05:07
10/11/17
05:07

bluebird bio assumed with a Hold from Buy at Jefferies

Jefferies analyst Biren Amin downgraded bluebird bio to Hold after assuming coverage of the name. The analyst views LentiGlobin in sickle cell disease the company's main value driver near-term and he's cautious that program improvements will translate to meaningful efficacy. He raised his price target for bluebird shares to $126 from $86.

  • 06

    Nov

BLUE bluebird bio
$131.65

0.15 (0.11%)

10/02/17
10/02/17
DOWNGRADE
Target $105

Underweight
bluebird bio downgraded to Underweight on sickle cell risk at Morgan Stanley
As previously reported, Morgan Stanley analyst Matthew Harrison downgraded bluebird bio (BLUE) to Underweight from Equal Weight, as he believes the risks ahead of the company's presentation of LentiGlobin sickle cell data at December's American Society of Hematology meeting remains underappreciated. The analyst, who notes the stock is up over 40% since Gilead's (GILD) acquisition of Kite Pharma (KITE) set off excitement about the CAR-T space that blue is also in, doesn't believe the ASH data will demonstrate the improvement in hemoglobin production necessary to increase confidence in sickle cell genetherapy, he tells investors. Harrison keeps a $105 price target on bluebird bio shares.
10/02/17
10/02/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PepsiCo (PEP) downgraded to Hold from Buy at Jefferies with analyst Kevin Grundy saying North American beverage trends continue to deteriorate and Pepsi's likely need for reinvestment should "cap the stock" over the next 12 months. 2. Western Digital (WDC) downgraded to Neutral from Outperform at Baird with analyst Tristan Gerra saying he believes the potential outcomes from the company's ongoing litigation with Toshiba (TOSYY) "range from neutral to significantly negative" and the ongoing fight will cap the stock's valuation in the near-term. 3. Uniti Group (UNIT) downgraded to Neutral from Overweight at JPMorgan with analyst Philip Cusick saying the "theme of Windstream's (WIN) distress continues to increase in volume." 4. Parker-Hannifin (PH) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Nigel Coe saying he sees a more balanced risk-reward following the stock's strong outperformance since the election. 5. bluebird bio (BLUE) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Matthew Harrison saying he believes the risks ahead of the company's presentation of LentiGlobin sickle cell data at December's American Society of Hematology meeting remains underappreciated. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/17
WELS
10/03/17
NO CHANGE
WELS
Outperform
bluebird bio should be bought on weakness, says Wells Fargo
Wells Fargo analyst Jim Birchenough reiterates an Outperform rating on shares of bluebird bio and recommends buying on weakness, following a call with management and what he believes to be flawed competitor analysis related to the companies LentiGlobin gene therapy program for Sickle Cell Disease. With concerns raised regarding correlation between ex vivo drug product vector copy number and in vivo peripheral vector copy number, the analyst believes that pooling of small patient numbers, from different studies, not consistently exposed to the same gene therapy product or transplant protocol, provides inadequate framework for correlation analysis and conclusion on prospects for clinical success in Sickle Cell Disease. Importantly, Birchenough argues that at the current bluebird bio share price of $120/share, only $16/share is attributable to Sickle Cell Disease, with an implied likelihood of success of only 10%, and that base value of $104/share can be supported by BCMA CAR-T, LentiGlobin for Beta Thalassemia, and gene therapy for adrenoleukodystrophy.
10/06/17
GSCO
10/06/17
INITIATION
Target $186
GSCO
Conviction Buy
bluebird bio reinstated with a Conviction Buy at Goldman Sachs
Goldman analyst Salveen Richter resumed coverage on bluebird with a Conviction Buy and $186 price target due to its leading position in the highly innovative gene and dell therapy fields, with a focus on curative/corrective one-time treatment.

TODAY'S FREE FLY STORIES

NFLX

Netflix

$202.68

3.19 (1.60%)

05:17
10/17/17
10/17
05:17
10/17/17
05:17
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EQT

EQT Corporation

$62.56

-0.45 (-0.71%)

, RICE

Rice Energy

$27.32

-0.2 (-0.73%)

05:17
10/17/17
10/17
05:17
10/17/17
05:17
Hot Stocks
EQT Corporation reiterates benefits of pending acquisition of Rice Energy »

EQT Corporation (EQT),…

EQT

EQT Corporation

$62.56

-0.45 (-0.71%)

RICE

Rice Energy

$27.32

-0.2 (-0.73%)

EQGP

EQT GP

$29.71

-0.53 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 14

    Nov

  • 15

    May

  • 16

    May

NFLX

Netflix

$202.68

3.19 (1.60%)

05:12
10/17/17
10/17
05:12
10/17/17
05:12
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CMC

Commercial Metals

$20.50

-0.28 (-1.35%)

, GGB

Gerdau

$3.57

-0.01 (-0.28%)

05:11
10/17/17
10/17
05:11
10/17/17
05:11
Upgrade
Commercial Metals, Gerdau rating change  »

Commercial Metals…

CMC

Commercial Metals

$20.50

-0.28 (-1.35%)

GGB

Gerdau

$3.57

-0.01 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SECO

Seeco Holding

$8.30

0.14 (1.72%)

05:07
10/17/17
10/17
05:07
10/17/17
05:07
Initiation
Seeco Holding initiated  »

Seeco Holding initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$198.41

-7.11 (-3.46%)

05:06
10/17/17
10/17
05:06
10/17/17
05:06
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

EV

Eaton Vance

$51.10

0.03 (0.06%)

05:02
10/17/17
10/17
05:02
10/17/17
05:02
Initiation
Eaton Vance initiated  »

Eaton Vance initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$31.48

0.2 (0.64%)

05:02
10/17/17
10/17
05:02
10/17/17
05:02
Initiation
Federated Investors initiated  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

JHG

Janus Henderson Group

$35.22

-0.08 (-0.23%)

05:01
10/17/17
10/17
05:01
10/17/17
05:01
Initiation
Janus Henderson Group initiated  »

Janus Henderson Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LM

Legg Mason

$37.63

-1.11 (-2.87%)

05:01
10/17/17
10/17
05:01
10/17/17
05:01
Initiation
Legg Mason initiated  »

Legg Mason initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

WETF

WisdomTree

$11.00

0.01 (0.09%)

05:00
10/17/17
10/17
05:00
10/17/17
05:00
Initiation
WisdomTree initiated  »

WisdomTree initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$15.27

0.52 (3.53%)

04:59
10/17/17
10/17
04:59
10/17/17
04:59
Downgrade
Freeport McMoRan rating change  »

Freeport McMoRan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ERJ

Embraer

$21.42

-0.63 (-2.86%)

, EADSY

Airbus

$22.75

-0.07 (-0.31%)

04:56
10/17/17
10/17
04:56
10/17/17
04:56
Downgrade
Embraer, Airbus rating change  »

Embraer downgraded to…

ERJ

Embraer

$21.42

-0.63 (-2.86%)

EADSY

Airbus

$22.75

-0.07 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$114.58

0.72 (0.63%)

, CSOD

Cornerstone OnDemand

$39.02

0.02 (0.05%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Stephens human capital management team holds analyst/industry conference call »

Enterprise Software…

ADP

ADP

$114.58

0.72 (0.63%)

CSOD

Cornerstone OnDemand

$39.02

0.02 (0.05%)

MSFT

Microsoft

$77.65

0.16 (0.21%)

ORCL

Oracle

$48.86

0.25 (0.51%)

PAYC

Paycom

$78.99

-0.9 (-1.13%)

PCTY

Paylocity

$50.08

0.17 (0.34%)

SAP

SAP

$111.84

-0.88 (-0.78%)

ULTI

Ultimate Software

$194.45

-3.47 (-1.75%)

WDAY

Workday

$107.23

-2.13 (-1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 26

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 05

    Nov

  • 08

    Nov

  • 15

    Nov

WES

Western Gas Partners

$50.92

-0.38 (-0.74%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Western Gas Partners to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Stephens food & agribusiness analyst holds an analyst/industry conference call »

Food & Agribusiness…

SFNC

Simmons First National

$58.90

0.45 (0.77%)

, OKSB

Southwest Bancorp

$28.05

0.15 (0.54%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Southwest Bancorp to host special shareholder meeting »

Special Shareholder…

SFNC

Simmons First National

$58.90

0.45 (0.77%)

OKSB

Southwest Bancorp

$28.05

0.15 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 23

    Oct

CLSD

Clearside Biomedical

$7.77

0.03 (0.39%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Clearside Biomedical management to meet with JMP Securities »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AKR

Acadia Realty Trust

$30.26

-0.2 (-0.66%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Acadia Realty Trust management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 03

    Nov

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Citigroup to hold a conference »

9th Annual Australian…

GSM

Ferroglobe

$14.56

0.39 (2.75%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Ferroglobe to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

  • 15

    Nov

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Senate Banking, Housing & Urban Affairs Committee to hold a hearing »

The Committee holds a…

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Senate Health, Ed, Labor & Pensions Committee holds a hearing »

The Committee holds a…

MRK

Merck

$63.34

-0.05 (-0.08%)

, GSK

GlaxoSmithKline

$40.86

-0.15 (-0.37%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
European Society of Gene & Cell Therapy will hold a conference »

25th Anniversary Congress…

MRK

Merck

$63.34

-0.05 (-0.08%)

GSK

GlaxoSmithKline

$40.86

-0.15 (-0.37%)

TECH

Bio-Techne

$122.54

0.89 (0.73%)

PLL

Pall Corp.

ICEL

Cellular Dynamics

ABEO

Abeona Therapeutics

$16.70

0.6 (3.73%)

KITE

Acquired by GILD 9/17

PFE

Pfizer

$35.98

-0.36 (-0.99%)

BMRN

BioMarin

$94.66

-0.46 (-0.48%)

SHPG

Shire

$155.28

1.21 (0.79%)

TIG

TiGenix

$24.08

-0.46 (-1.87%)

BIIB

Biogen

$335.68

-1.96 (-0.58%)

QURE

uniQure

$11.98

1.27 (11.86%)

SGMO

Sangamo

$14.85

-0.1 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 18

    Oct

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 31

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 29

    Nov

  • 30

    Nov

  • 02

    Feb

  • 28

    Feb

  • 17

    Oct

UBS

UBS

, CME

CME Group

$137.52

0.21 (0.15%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Futures Industry Association to hold an expo »

33rd Annual FIA Futures…

UBS

UBS

CME

CME Group

$137.52

0.21 (0.15%)

NDAQ

Nasdaq

$74.11

-0.23 (-0.31%)

ICE

IntercontinentalExchange

$68.40

-0.99 (-1.43%)

CBOE

CBOE Holdings

$109.70

-0.8 (-0.72%)

BAC

Bank of America

$26.24

0.41 (1.59%)

GS

Goldman Sachs

$242.41

3.88 (1.63%)

JPM

JPMorgan

$97.84

1.98 (2.07%)

CS

Credit Suisse

$15.91

0.08 (0.51%)

C

Citi

$71.77

-0.34 (-0.47%)

AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

MS

Morgan Stanley

$48.94

0.64 (1.33%)

WFC

Wells Fargo

$53.80

0.11 (0.20%)

AMTD

TD Ameritrade

$47.77

0.46 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 20

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 02

    Nov

  • 02

    Nov

  • 05

    Nov

  • 07

    Nov

  • 07

    Nov

  • 20

    Nov

  • 29

    Nov

  • 15

    Jan

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.